Ingredients INGREDIENTS INCI [CTFA]: AQUA/WATER, STEARYL ALCOHOL, ETHANOLAMINE, PROPYLENE GLYCOL, CETYL ALCOHOL, CETEARETH-25, COCAMIDE MEA, TOLUENE-2,5-DIAMINE SULFATE, CETETH-2, POLYQUATERNIUM-6, ARGANIA SPINOSA KERNEL OIL, HYDROLYZED KERATIN, PANAX GINSENG ROOT EXTRACT, DIMETHICONE, PALMITIC ACID, ASCORBIC ACID, EDTA, SODIUM HYDROSULFITE, SODIUM SULFITE, BUTYLENE GLYCOL, 2-METHYLRESORCINOL, P-AMINOPHENOL, 4-CHLORORESORCINOL, M-AMINOPHENOL, 2-AMINO-3-HYDROXYPYRIDINE
Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3
Oestreicher J, Morgan B
If approved, CagriSema would provide patients and healthcare professionals with an additional treatment option supported by results from the REDEFINE clinical program, including robust efficacy, high treatment completion rates, and a tolerability profile consistent with its underlying pharmacology
This is why IV drips can achieve therapeutic levels that oral supplementation typically cannot match